• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤血管网络的发展。

The development of tumour vascular networks.

机构信息

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, 5000, Australia.

South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, 5000, Australia.

出版信息

Commun Biol. 2021 Sep 22;4(1):1111. doi: 10.1038/s42003-021-02632-x.

DOI:10.1038/s42003-021-02632-x
PMID:34552183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8458341/
Abstract

The growth of solid tumours relies on an ever-increasing supply of oxygen and nutrients that are delivered via vascular networks. Tumour vasculature includes endothelial cell lined angiogenesis and the less common cancer cell lined vasculogenic mimicry (VM). To study and compare the development of vascular networks formed during angiogenesis and VM (represented here by breast cancer and pancreatic cancer cell lines) a number of in vitro assays were utilised. From live cell imaging, we performed a large-scale automated extraction of network parameters and identified properties not previously reported. We show that for both angiogenesis and VM, the characteristic network path length reduces over time; however, only endothelial cells increase network clustering coefficients thus maintaining small-world network properties as they develop. When compared to angiogenesis, the VM network efficiency is improved by decreasing the number of edges and vertices, and also by increasing edge length. Furthermore, our results demonstrate that angiogenic and VM networks appear to display similar properties to road traffic networks and are also subject to the well-known Braess paradox. This quantitative measurement framework opens up new avenues to potentially evaluate the impact of anti-cancer drugs and anti-vascular therapies.

摘要

实体肿瘤的生长依赖于通过血管网络不断增加的氧气和营养物质供应。肿瘤血管包括内皮细胞排列的血管生成和较少见的癌细胞排列的血管生成拟态(VM)。为了研究和比较血管生成和 VM 过程中形成的血管网络的发展(这里以乳腺癌和胰腺癌细胞系为例),我们利用了许多体外检测方法。通过活细胞成像,我们进行了大规模的网络参数自动提取,并确定了以前未报道过的特性。我们表明,对于血管生成和 VM 而言,特征性的网络路径长度随时间的推移而减少;但是,只有内皮细胞增加了网络聚类系数,从而在其发育过程中保持了小世界网络特性。与血管生成相比,VM 网络的效率通过减少边和顶点的数量以及增加边的长度得到了提高。此外,我们的结果表明,血管生成和 VM 网络似乎具有与道路交通网络相似的特性,并且也受到著名的 Braess 悖论的影响。这种定量测量框架为评估抗癌药物和抗血管治疗的影响开辟了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/6daa9035b392/42003_2021_2632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/23e4ee91c49c/42003_2021_2632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/91047bbca174/42003_2021_2632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/916038fb9c55/42003_2021_2632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/3cfc3e63a97b/42003_2021_2632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/6daa9035b392/42003_2021_2632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/23e4ee91c49c/42003_2021_2632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/91047bbca174/42003_2021_2632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/916038fb9c55/42003_2021_2632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/3cfc3e63a97b/42003_2021_2632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da9/8458341/6daa9035b392/42003_2021_2632_Fig5_HTML.jpg

相似文献

1
The development of tumour vascular networks.肿瘤血管网络的发展。
Commun Biol. 2021 Sep 22;4(1):1111. doi: 10.1038/s42003-021-02632-x.
2
Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.原肌球蛋白的下调阻断白细胞介素-8的利用并抑制乳腺癌细胞中的血管生成拟态。
Exp Biol Med (Maywood). 2017 Mar;242(6):573-583. doi: 10.1177/1535370216685435. Epub 2017 Jan 6.
3
Immunohistochemistry for VM Markers.免疫组织化学检测 VM 标志物。
Methods Mol Biol. 2022;2514:141-152. doi: 10.1007/978-1-0716-2403-6_14.
4
Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer.几丁质酶 3 样蛋白 1(CHI3L1)促进宫颈癌中的血管生成拟态形成。
Pathology. 2018 Apr;50(3):293-297. doi: 10.1016/j.pathol.2017.09.015. Epub 2018 Feb 13.
5
Vascular mimicry in cultured head and neck tumour cell lines.培养的头颈肿瘤细胞系中的血管拟态
Head Neck Oncol. 2011 Dec 23;3:55. doi: 10.1186/1758-3284-3-55.
6
Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.化合物 DMBT 对缺氧诱导的人乳腺癌血管生成拟态的抑制作用。
Biomed Pharmacother. 2017 Dec;96:982-992. doi: 10.1016/j.biopha.2017.11.137. Epub 2017 Dec 6.
7
Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.血管网络中血流的数学建模:对肿瘤诱导的血管生成和化疗策略的影响。
Bull Math Biol. 2002 Jul;64(4):673-702. doi: 10.1006/bulm.2002.0293.
8
Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.多靶点NGR修饰脂质体识别胶质瘤肿瘤细胞和血管生成拟态以改善抗胶质瘤治疗
Oncotarget. 2016 Jul 12;7(28):43616-43628. doi: 10.18632/oncotarget.9889.
9
cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.cRGD 功能化纳米颗粒用于抗血管内皮依赖性和抗血管生成拟态的联合治疗,以抑制卵巢癌细胞的增殖。
Acta Biomater. 2019 Aug;94:495-504. doi: 10.1016/j.actbio.2019.06.039. Epub 2019 Jun 25.
10
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.CD36 通过介导与细胞外基质的黏附促进黑色素瘤中的血管生成拟态。
BMC Cancer. 2021 Jul 2;21(1):765. doi: 10.1186/s12885-021-08482-4.

引用本文的文献

1
Role and Mechanisms of Angiogenesis in Tumours.肿瘤血管生成的作用及机制
Biology (Basel). 2025 Jun 25;14(7):756. doi: 10.3390/biology14070756.
2
Leptin-Upregulated Metastasis-Associated Protein 1 Promotes Vasculogenic Mimicry in Breast Cancer Cells.瘦素上调的转移相关蛋白1促进乳腺癌细胞的血管生成拟态
Int J Mol Sci. 2025 Jun 15;26(12):5726. doi: 10.3390/ijms26125726.
3
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.内源性旁观者杀伤机制增强新型FAP特异性CAR-T细胞对胶质母细胞瘤的活性。

本文引用的文献

1
Platelets disrupt vasculogenic mimicry by cancer cells.血小板通过破坏肿瘤细胞的血管生成拟态来发挥作用。
Sci Rep. 2020 Apr 3;10(1):5869. doi: 10.1038/s41598-020-62648-x.
2
Truels and strategies for survival.生存之道与策略。
Sci Rep. 2019 Jun 20;9(1):8996. doi: 10.1038/s41598-019-45253-5.
3
Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.苦马豆素抑制人三阴性乳腺癌 MDA-MB-231 细胞系的血管生成拟态。
Clin Transl Immunology. 2024 Jul 5;13(7):e1519. doi: 10.1002/cti2.1519. eCollection 2024.
4
The in vitro dynamics of pseudo-vascular network formation.体外伪血管网络形成的动力学。
Br J Cancer. 2024 Aug;131(3):457-467. doi: 10.1038/s41416-024-02722-7. Epub 2024 Jun 20.
5
Incorporating temporal information during feature engineering bolsters emulation of spatio-temporal emergence.在特征工程中融入时间信息可以增强对时空涌现的模拟。
Bioinformatics. 2024 Mar 4;40(3). doi: 10.1093/bioinformatics/btae131.
6
Synthesis, Characterizations, and Quantum Chemical Investigations on Imidazo[1,2-]pyrimidine-Schiff Base Derivative: ()-2-Phenyl--(thiophen-2-ylmethylene)imidazo[1,2-]pyrimidin-3-amine.咪唑并[1,2 - ]嘧啶 - 席夫碱衍生物()-2 - 苯基 - (噻吩 - 2 - 基亚甲基)咪唑并[1,2 - ]嘧啶 - 3 - 胺的合成、表征及量子化学研究
ACS Omega. 2023 Dec 15;9(1):837-857. doi: 10.1021/acsomega.3c06841. eCollection 2024 Jan 9.
7
Radiomics characterization of tissues in an animal brain tumor model imaged using dynamic contrast enhanced (DCE) MRI.利用动态对比增强(DCE)MRI 对动物脑肿瘤模型中的组织进行放射组学特征分析。
Sci Rep. 2023 Jul 2;13(1):10693. doi: 10.1038/s41598-023-37723-8.
8
Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities.攻克胰腺导管腺癌中的纤维化堡垒:挑战与机遇
Cancers (Basel). 2023 Apr 18;15(8):2354. doi: 10.3390/cancers15082354.
9
Hip osteoarthritis: A novel network analysis of subchondral trabecular bone structures.髋骨关节炎:对软骨下小梁骨结构的新型网络分析
PNAS Nexus. 2022 Nov 21;1(5):pgac258. doi: 10.1093/pnasnexus/pgac258. eCollection 2022 Nov.
10
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows.节拍化疗用于转移性乳腺癌治疗:光明与阴影之间的临床及临床前数据
J Clin Med. 2022 Aug 12;11(16):4710. doi: 10.3390/jcm11164710.
Biomed Res Int. 2019 Jan 6;2019:6543230. doi: 10.1155/2019/6543230. eCollection 2019.
4
Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.血管生成拟态研究进展综述——肿瘤治疗的潜在靶点
Cancer Manag Res. 2018 Aug 2;10:2429-2437. doi: 10.2147/CMAR.S164675. eCollection 2018.
5
On detection of periodicity in C-reactive protein (CRP) levels.检测 C 反应蛋白(CRP)水平的周期性。
Sci Rep. 2018 Aug 10;8(1):11979. doi: 10.1038/s41598-018-30469-8.
6
Non-angiogenic tumours and their influence on cancer biology.非血管性肿瘤及其对癌症生物学的影响。
Nat Rev Cancer. 2018 May;18(5):323-336. doi: 10.1038/nrc.2018.14. Epub 2018 Mar 9.
7
Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.曲匹地尔通过抑制 VE-钙黏蛋白和趋化因子配体 2 基因的表达,强力抑制胰腺癌细胞介导的血管生成拟态。
Eur J Pharmacol. 2018 Jan 5;818:593-603. doi: 10.1016/j.ejphar.2017.11.019. Epub 2017 Nov 21.
8
HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.低氧诱导因子-2α通过调节Twist1与血管内皮钙黏蛋白启动子的结合来促进胰腺癌中血管生成拟态的形成。
Oncotarget. 2017 Jul 18;8(29):47801-47815. doi: 10.18632/oncotarget.17999.
9
Tumor Neoangiogenesis and Flow Congestion: A Parallel to the Braess Paradox?肿瘤新生血管生成与血流淤滞:与布雷斯悖论相似?
Circ Res. 2016 Sep 2;119(6):711-3. doi: 10.1161/CIRCRESAHA.116.309411.
10
Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.肿瘤血管生成拟态预测癌症患者预后不良:一项荟萃分析。
Angiogenesis. 2016 Apr;19(2):191-200. doi: 10.1007/s10456-016-9500-2. Epub 2016 Feb 22.